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Background: Pain is one of the first causes of medical consultation in the world and by extension of dental consul-
tation too. Orofacial pain comprehends the oral and facial regions including teeth, oral mucosa, gingiva, tongue and 
lips, but also the muscles of the jaw and neck, the temporomandibular joint, face, head and neck. Despite its highly 
estimated prevalence, it appears controversial and hard to quantify given the lack of common criteria to select the 
population under study and the difficulties to classify the different types of pain. Although for many patients the 
problem eventually fades after tissue healing, certain sub-chronic and chronic pain conditions remain notoriously 
undertreated. In this respect, animal models can be of great help.
Material and Methods: A systematic search was conducted in PubMed-Medline with appropriate keywords: orofa-
cial pain, prevalence and dentist. Seven groups were generated and a second search based on each of these groups 
and on animal models was made. Search was restricted to English and Spanish, but no time restriction was applied. 
Results and Conclusions: There are as yet few experimental models of orofacial pain: there hardly exists no other 
than trigeminal nerve injury for neuropathic pain, a bunch of oral squamous cell carcinoma models (mainly refe-
rred to the tongue) for cancer pain and none for the painful swelling of salivary glands. Similarly occurs for the 
burning mouth syndrome. A few more exist for inflammatory odontalgiae, aphthae, joint, myofascial and muscle 
inflammatory pains, although scarcely diverse as regards the nature of the noxious stimulus. Given the relevance of 
envisaging the mechanistic of the various types of orofacial pain, new experimental models are needed on the basis 
of the dentist’s perspective for their correct management.
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Introduction
Pain is one of the most frequent reasons for consulta-
tion in primary health care in the world (1). Although 
a highly variable prevalence has been estimated in the 
global population (~10-55% as stated by the Interna-
tional Association for the Study of Pain, IASP), today 
a prevalence of 19% is generally accepted for chronic 
pain in Europe (2). The elaboration of statistics appears, 
however, to be a challenging task for diverse reasons: 
the varied origin of the sample, the sex and age ratios of 
the sample population, the duration of the ailment, the 
data collection strategy or an overly lax nomenclature 
for different mechanisms and types of orofacial pain. 
Moreover, cultural and socioeconomic conditions may 
also influence (3-6). 
Orofacial pain is often referred, thereby interfering 
with its diagnosis. However, according to the IASP, for 
a significant number of patients pain may persist after 
the pain-producing stimulus is removed or even in the 
absence of a clear physical cause or illness. Such pain is 
considered chronic and generally requires a multidisci-
plinary and integrated approach.
Although the main, and often only, transmission pa-
thway considered is the trigeminal nerve, the fifth (trige-
minus), seventh (facialis) and ninth (glossopharyngeus) 
cranial nerves also contribute for most of the orofacial 
pain. Therefore it is not surprising that orofacial chronic 
pain is so difficult to classify and to cope with, espe-
cially in regard to some atypical algiae. In this respect, 
animal models can prove a good tool to understand the 
mechanisms and management of orofacial pain. 
Material and Methods
Firstly, a PubMed-Medline search was made using the 
following research sequence: “orofacial pain” AND 
“prevalence” AND “dentist” (n = 145 articles). In se-
lecting the studies, we reviewed the titles and abstracts 
to identify relevant publications, of which the complete 
text was then obtained. Search was restricted to English 
and Spanish, but no time restriction was applied. Based 
on these preliminary results, seven groups were genera-
ted: odontalgia (dental), oral mucositis (oral ulcer or in-
flammatory), muscle (or masseter), temporomandibular, 
neuropathic (trigeminal or facial), burning mouth syn-
drome and oral cancer (tongue or facial cancer). Then a 
second search was made with the terms: “animal model” 
(alternatively rat or mouse) AND “orofacial pain” AND 
each of the seven groups just cited. Same restriction cri-
teria as above were used.
Results
The most common orofacial disorders that can evolve 
with pain are odontalgia, soft tissue mucosa ulceration, 
muscle and joint pain and neuralgiae; considering bur-
ning mouth syndrome and cancer pain as groups apart. 
-Animal models of odontalgia.
One of the first dental inflammatory pain models de-
veloped in rodents consists in the mechanical exposu-
re of the pulp of two alternate or the three mandibular 
and/or maxillary molars with a round bur (#2) at high 
speed in rats (7). Although pulpitis and periapical le-
sions correlate with the ailment observed in patients, the 
reproducibility of the model is questionable: different 
dental crowns may exhibit varying degrees of damage. 
And hence, pulpal and neural pooled responses might 
be rather inaccurate, misleading or inconsistent. Today, 
mechanical exposure of both pulp horns of the mandi-
bular (or maxillary) first molar in mice (or rats) is more 
commonly used (8) (Fig. 1A). Unlike the previous case, 
erosion of the occlusal surface of the tooth may be per-
formed uni- or bilaterally by means of a dental drill with 
round bur (#1/4) at low speed and the injury extension 
visualised under an operating microscope to check that 
both pulp horns are affected. Body weight and water and 
food consumption can be monitored as proxy measures 
of general discomfort. In addition, the use of an infra-
red beam-based activity meter during daytime –rats are 
nocturnal– can be used to determine any possible altera-
tion of the spontaneous locomotor activity at typically 
sleeping or rather resting moments. Increased frequency 
and duration of face rubbing on the fore- or hindlimbs 
towards the injured area and conditioned-reinforcement 
tests can also shed light on the spontaneous pain an ani-
mal is experiencing. The consumption of a sweet solu-
tion (water + sucrose), for instance, has been reported to 
be directly proportional to the magnitude of the nocicep-
tive component that a mouse with dental pulp injury is 
suffering (9). That is, animals experiencing odontalgia 
drink more sweet solution than control animals. Further 
identification of anxiety behaviours by the open field or 
elevated plus maze tests will give a multidimensional in-
sight of the pain being experienced by these animals (9). 
Given that dentalgia also depends on the type of tooth 
and its innervation, an alternative to the previous models 
consists in the injection of proinflammatory agents in the 
rat mandibular incisor pulp (10) (Fig. 1B). Briefly, the 
distal 2 to 2.5mm of the mandibular incisors are care-
fully cut with a fine bone gouge forceps (rongeur) and 
an artificial crown of polyethylene tubing is placed so it 
wraps both incisors. A 1–2 mm sealed metal cap tops off 
the surface of the crown to close the incisal edge. Even-
tually, the opposite end of the crown is fixed on the in-
cisors by a 0.01inch orthodontic stainless steel wire and 
rats are allowed to recover in their cages for at least two 
days before behavioural assessment; then, restrained in 
a plastic cone and a 10μl volume of the irritant substance 
is carefully administered into the artificial crown under 
an operating microscope. Capsaicin (10-100μg/μl; 10μl) 
or alternatively formalin (2.5%; 10μl) can be used, and 
behaviour is assessed immediately after a single injec-
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Fig. 1: A) Model stimulating pulpitis: dental pulp injury (DPI) model. B) Model stimulating pulpitis: application of chemical irritants to inci-
sors. C) Model of atypical odontalgia. D| Model of tooth movement (orthodontia). Refer to text for a more detailed explanation.
tion of the irritant substance according to the following 
grading score system:
-score    type of behaviour
   0 normal
   1 abnormal head movements (mild head shaking 
or placement of the jaw on the floor)
   2 continuous shaking of the lower jaw
   3 excessive rubbing of the mouth with the fore-
limbs 
The total time spent in each of the four scales is estima-
ted over successive 3min blocks during a total time of 
60min. Eventually, comparisons between the time-res-
ponse curves in control and treated animals are made.
The extraction of mandibular first molars in rats could 
constitute a model to study peripheral and central sensi-
tisation occurring in some atypical odontalgia (11) (Fig. 
1C). However, its use remains merely residual so far. 
Interestingly, some works on orthodontics have also 
been developed as models of tooth movement in rat. The 
orthodontic device commonly consists of a stainless ste-
el coil spring attached to both upper incisors by a metal 
wire on one edge and to the maxillary first molar on the 
other –uni- or bilaterally (12)–. Optimum force magni-
tude and carrying duration varies greatly between the di-
fferent works: from two days up to four weeks and from 
10 to 100g. The orthodontic treatment eventually results 
in the displacement of teeth, affecting either the incisors 
or the oral cavity (mesio- or distobuccally) as required 
(Fig. 1D). Again, body weight and food consumption 
can be considered as indirect measures of general dis-
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comfort; altered sleep/wake patterns and anxiogenic be-
haviour as well. 
-Animal models of oral mucositis-induced pain.
Oral ulcerations are relative common recurrent mucosal 
lesions often identified with pain; animal models for oral 
mucositis are most currently based on chemical lesions. 
A model of pain induced by unilateral chemical ulcera-
tion of the oral mucosa consists in the injection of hydro-
chloric acid (1%; 20µl) into oral submucosa of athymic 
nude mice (13). The ulcer reaches its maximal extension 
the first day following chemical administration and gra-
dually reduces during the next two weeks. As previously 
mentioned, regular assessment of body weight and food 
and water consumption may yield information on the le-
vel of discomfort experienced by the animal. For evoked 
pain, applying von Frey filaments or a radiant heat sour-
Fig. 2: A) Model of chemical ulceration of the oral mucosa. Hydrochloric acid (1%; 20µl) or acetic acid (99.7%; 
50µl) are injected into one side buccal mucosa. Evoked-pain responses to light touch and noxious heat are 
regularly assessed during the next 14 days. B) Model of physical ulceration of the oral mucosa. Piercing instal-
lation and ulcerative device implantation and removal are performed under anaesthesia. Upon device removal 
behavioural response is determined. Behavioural assessments (rubbing of the face or von Frey test) are always 
conducted at a fixed time on a daily basis during 5 days.
ce to the external area of the cheek or vibrissae area will 
enable to assess the existence of tactile allodynia or heat 
hyperalgesia respectively (Fig. 2A). 
Recently, a complex model of physical ulceration of the 
labial fornix of the oral mucosa consisting in a metal 
wire attached to the mandibular incisors of a rat has been 
developed (14). After one day, the device is withdrawn 
and the behaviour assessed during the next 5 days. The 
time spent rubbing the face with both forelimbs can be 
assessed during 10min daily to serve as a spontaneous 
pain measurement. Additionally, the existence of tac-
tile allodynia can also be evaluated. For this purpose, 
previously to the implantation of the physical ulcerative 
device, a small piercing is installed just beneath the skin 
below the lower lip and above the chin in anaestheti-
sed rats. Rats are then trained for 3-4 days to introduce 
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their head (actually their perioral region) into a plastic 
or acrylic restrainer. After training fulfilment the device 
is implanted and, the following day, after removal, the 
use of a neodymium magnet when the rat enters the res-
trainer will enable to expose the ulcerative region to the 
researcher. The evoked-pain response (head withdrawal 
threshold) to von Frey hair stimulation onto the labial 
fornix will be determined (Fig. 2B). 
-Animal models of inflammatory pain in the facial re-
gion.
The model of formalin-induced facial pain (15) consists 
in the administration of 2.5% formalin (50μl) into the 
facial vibrissae (one side upper lip lateral to the nose) 
of non-anaesthetised rats. Nociceptive behaviour is de-
termined immediately after the injection. The time rats 
spend rubbing the injected area is calculated in blocks 
of 3min during a total time of 30min. A typical biphasic 
nociceptive response may be observed after formalin in-
jection, with the first phase, between 0 and 3 min, reflec-
ting the direct chemical stimulation of the nociceptive 
terminals, and the second phase, between 12 and 30 min, 
representing the orofacial inflammatory pain. The model 
of capsaicin-induced facial pain (2μg/50μl) (16) consti-
tutes a modification of this model, and same behaviour 
is analysed.
Unlike the previous two models, the model of carragee-
nan-induced facial pain (100μg/50μl) (16) focuses on 
an evoked-pain response rather than on a spontaneous 
pain response. The latency to display head withdrawal or 
alternatively vigorous flicking of the snout upon stimu-
lation of the vibrissae pad with a radiant heat source is 
registered before (baseline), immediately after carragee-
nan injection and every hour during the next 6h. A 20s 
cut-off time is used in order to prevent tissue damage. 
The model of Complete Freund’s Adjuvant (CFA)-indu-
ced pain (50μl) (17) in the vibrissae area of anaestheti-
sed rats represents another model of facial inflammatory 
pain. Similar to the previous case, an evoked-pain res-
ponse is registered: either the head withdrawal threshold 
or face stroking with the forepaw to von Frey hair stimu-
lation of the vibrissae area. 
-Animal models of muscle pain.
Myofascial pain is together with neuralgia one of the 
most complex types of orofacial chronic pain to treat 
and also possesses one of the highest incidence rates. 
Most experimental animal models, however, refer strict-
ly to the masseter muscle: model of pain induced by the 
injection of glutamate (1–2M; 40μl) (18), model of pain 
induced by the injection of hypertonic saline (5% NaCl; 
100μl) (19) or model of pain induced by the injection of 
CFA (15μl) (20) into the masseter muscle. All of them 
are based, as well, on the unilateral single administra-
tion of pro-inflammatory chemicals through a carefully 
inserted catheter. In the first case, glutamate is adminis-
tered under isoflurane light anaesthesia and nociceptive 
behaviour is evaluated by applying von Frey filaments 
onto the skin surface of the injected area. Registers of 
the head withdrawal thresholds are noted 5, 15, 30, 45, 
60, and 90min after injection on conscious (awake) ani-
mals. In the second case, both administration of hyper-
tonic saline (HS) and behavioural assessment take place 
under light anaesthesia. HS produces a short acting and 
non-sensitising ipsilateral hindpaw shaking behaviour. 
In the third case CFA administration is injected under 
light isoflurane anaesthesia so the animals can rapidly 
recuperate. After 10min, animals are video-recorded for 
a 60-min period and the grooming patterns are further 
calculated in 10 blocks of 6min, considering the dura-
tion of time they spent grooming the injected area and 
the time that they occur. A fourth model of inflammatory 
pain in the masseter muscle consists in the injection of 
carrageenan (3-9%; 100μl) (21). A single administration 
of carrageenan is injected under no anaesthesia and no-
ciceptive behaviour is evaluated by applying von Frey 
filaments, a pressure application measurement (PAM) 
device or a hot pen (45ºC) onto the skin surface of the 
injected area 4h, 1, 2, 7 and 14 days after injection. A 20s 
cut-off time is used for the latter test in order to prevent 
tissue damage.
Finally, a model of pain in the masticatory muscle of 
the temporal region induced by psychological stress has 
been developed (22). A communication box made of 16 
compartments (dimensions: 16×16cm each) separated 
from each other by transparent plastic walls with nume-
rous holes and a floor formed by a metal wire mesh is 
connected to a 48V generator. A plastic surface on top 
of the mesh is placed only in 8 alternate compartments. 
This way, although 16 rats can be introduced into the 
communication box, 8 of them will receive no electric 
discharge. However, these animals will be exposed to 
the screaming, urine and faeces odour and bounds of the 
neighbouring rats through the holes on the walls. During 
a first phase of 7 days, all rats are placed daily in the 
communication box for 1hour in order to accustom to 
the test conditions (in absence of any electric discharge). 
In a second phase of 14 days, the rats in direct contact 
with the metal wire will receive daily electric discharges 
every 2 seconds during 1 hour. An independent group 
of rats will be placed in a different communication box 
receiving no electric discharges during the 28-day time 
period as a control. The elevated plus maze test may 
be used (once per week) to assess the anxiety level in 
the animals. The von Frey test may be applied on the 
masseter and temporary muscles to evaluate the head 
withdrawal threshold –or alternatively the vocalization– 
to a tactile stimulus. Body weight can also be assessed 
as an indirect method to determine general discomfort 
all along the process. Rats located next to those recei-
ving electric discharges will exhibit increased aversion 
to open spaces (anxiety symptom) in the elevated plus 
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maze test and lower head withdrawal thresholds in the 
von Frey test than control rats (communication box not 
electrically stimulated) (22).
-Animal models of joint pain.
The administration of different substances into the tem-
poromandibular joint (TMJ) accurately recreates the 
type of pain experienced by many patients with TMJ di-
sorders: model of inflammatory pain induced by forma-
lin injection (2.5%; 50μl) (15), model of inflammatory 
pain induced by CFA injection (50μl) (23) or model of 
inflammatory pain induced by injection of mustard oil 
(20%; 25μl) (24) into the TMJ. Besides inflammatory 
pain, mixed pain (that further combines nociceptive and 
neuropathic pain) has also been studied. In this respect, 
a model of osteoarthritis pain induced by monosodic io-
doacetate (MIA; 0.5mg; 50μl) injection into the superior 
compartment of the TMJ has recently been developed 
(25). MIA injection affects the temporal fossa, but espe-
cially the condylar cartilage and the subchondral bone. 
Chondrocyte death already occurs within the first day, 
with a maximum pain peak after three days. The mo-
del was first aimed at the knee diarthrosis and is con-
sistent with a biphasic nociceptive nature: an early in-
flammatory phase in the first week and a second, chronic 
phase, starting two weeks post-MIA injection (26). 
In all the cited models, the existence of allodynia can be 
assessed as previously mentioned, by means of von Frey 
filaments. Body weight and water and food consump-
tion can be used as indirect methods to quantify general 
discomfort, which, in combination with the open-field, 
hole-board, elevated plus maze and actimeter tests may 
provide information of the psychological aspect of pain.
-Animal models of neuralgia. 
Orofacial neuropathic pain may result in a variety of le-
sions or disorders and nowadays represents a not easily 
solvable problem. Consequentially, numerous animal 
models have been developed: model of chronic constric-
tion injury induced by ligation of the infraorbital portion 
of the trigeminal nerve (maxillary division) (27), model 
of pain induced by trigeminal selective transections or 
the spared nerve injury model induced by ligation and 
consequent excision of the main branches of the infraor-
bital nerve innervating the vibrissae (28). In all the three 
models, tactile evoked allodynia is assessed by means 
of von Frey filaments (29), although cold allodynia and 
heat hyperalgesia may additionally be evaluated (30) 
(Fig. 3A). 
In the last years, a model of facial neuralgia has emer-
ged (31). The model presents two variants. In the first 
one, the lesion is irreversible: approximately 1mm of 
Fig. 3: A) Animal models of trigeminal neuralgia. Ligation (upper left), complete transection (upper middle) or ligation with ulterior exci-
sion (upper right) of the infraorbital nerve or associated branches. B) Animal models of facial neuralgia. Complete transection (lower left) or 
clamping (lower right) of the buccal and mandibular nerves.
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the mandibular and buccal branches of the facial nerve 
are excised. In the second, the lesion is reversible: the 
branches aforementioned are compressed in one direc-
tion with a clamp for 30s and then perpendicular to this 
sense for other extra 30s (Fig. 3B). Although the model 
has only been used to assess the locomotor activity so 
far, microglial activation has been observed in primary 
motor cortex of vibrissae after both types of injury (31), 
indicating the existence of central sensitisation.
-Animal models of burning mouth syndrome.
The development and implementation of animal models 
of burning mouth syndrome constitutes still nowadays 
a challenge for basic research. Nevertheless, a model of 
zinc deficiency in rats (32) on a low-zinc diet (2.3 mg/
kg) alternating weekly with a normal diet (50 mg/kg) in 
20 weeks has been developed. Just the histology of the 
tongue has been analysed so far. However, food intake 
has been used as a symptom of general discomfort.
-Animal models of cancer pain.
Oral Squamous Cell Carcinoma (OSCC) is one of the 
most common malignant neoplasms and the most com-
mon neoplasm in the oral cavity (33). Despite improve-
ments in the treatment of OSCC, high recurrence rates 
and morbidity make the use of animal models a good 
tool to help throw light on how to face cancer pain. More 
particularly when the mechanisms responsible for oral 
cancer pain are yet to be fully determined (34). 
The model of tongue OSCC induced by 4-nitroquinoline 
1-oxide (4-NQO) accurately reproduces the pathology 
occurring in humans: development of an OSCC accom-
panied by dysplasia, papilloma and tongue lesions. Hen-
ce, this model represents one of the most widely used 
methods to study oral cancer in both rats (35) and mice 
(36). The carcinogen 4-NQO is daily administered in 
the drinking water or alternatively brushed on the ton-
gue of anaesthetised animals three times weekly during 
16 weeks (37). The model of tongue OSCC induced by 
the implantation of the human HSC-2 cell line in athy-
mic mice (38) constitutes a modification of this model. 
Decreased eating behaviours and food intake, generally 
associated to the psychological aspect of pain, have been 
identified in both models.
Carcinoma-induced pain has also been studied in other 
intra- and extraoral regions. The model of subperiosteal 
abscess-induced cancer pain consists in the subperios-
teal implantation of the rat SCC-158 line into the lower 
gum in rats (39). Assessment of pain-evoked responses 
is performed as previously mentioned: on the one hand, 
mechanical sensitivity of the whisker pad (maxillary 
nerve region) and the submandibular skin (mandibular 
nerve region) is evaluated with von Frey filaments and, 
on the other hand, thermal sensitivity is determined by 
gently pressing the snout of the animal against a heat 
plate (55ºC). Head withdrawal thresholds and head wi-
thdrawal latencies (or alternatively the latency to vocali-
zation) are registered respectively. Additionally, the mo-
del of OSCC induced by subcutaneous implantation of 
the rat Walker 256 cell line into the whisker pad in rats 
(34) reproduces in a precise way the typical spontaneous 
pain, allodynia and hyperalgesia developed in many pa-
tients with an extraoral facial cancer. The time that the 
animal spends performing face wash strokes directed to 
the injected area is registered during 10min at a fixed 
time on a daily basis during several days. Head with-
drawal thresholds to von Frey hairs and head withdrawal 
latencies to a radiant heat source are also evaluated.
Discussion
Orofacial pain and particularly oral pain have been 
underresearched and underrecognized for many years, 
compared to other types of pain in different anatomical 
regions. Furthermore, an overly lax nomenclature for the 
different mechanisms and types of orofacial pain has led 
to a lack of common criteria and to the existence of dis-
tinct nominations for a same type of pain. Moreover, the 
development of Orofacial Pain Units gathering together 
experts on the stomatognathic and nociceptive systems 
are still lacking. 
In addition, although the clinical ethics committees for 
biomedical research consider the use of experimental 
animals a moral obligation prior to clinical assays, there 
is a shortage and scarce knowledge of experimental ani-
mal models for orofacial pain. The summary table below 
(Table 1, 1 continue) shows most of the different animal 
models existing for the distinct types of orofacial pain 
raised in this work. 




TYPE OF PAIN ANIMAL MODEL 
Odontalgia  
Caries  dental pulp mechanically exposed 
Caries or dental hypersensitivity subsequent to a 
disease 
capsaicin-induced dental nociception 
formalin-induced dental nociception 
Dental hypersensitivity resulting from a surgical 
procedure or orthodontic treatment 
unilateral orthodontic implant 
bilateral orthodontic implant (mesial displacement) 
bilateral orthodontic implant (distobuccal displacement)  
Cracked tooth syndrome – 
Maxillary sinusitis of odontogenic origin – 
Superficial somatic  
(Recurrent) aphthous stomatitis, pemphigus, 
lichen planus 
hydrochloric acid-induced submucosal nociception 
acetic acid-induced submucosal nociception 
Herpes simplex physical ulceration of the lip fornix mucosa 
Oclussal trauma – 
Necrotising ulcerative gingivitis – 
Necrotising ulcerative periodontitis – 
Necrotising sialometaplasia – 
Acute necrotising sialoadenitis – 
Sialolitiasis – 
Acute bacterian Parotiditis – 
Acute epidemic Parotiditis – 
Candidiasis – 
Facial   
Facial inflammatory pain trigeminal formalin-evoked pain 
capsaicin evoked trigeminal pain 
carrageenan edema in the vibrissal pad 
CFA edema in the vibrissal pad 
Muscle  
Myofascial  glutamate-evoked jaw muscle pain (masseter) 
hypertonic saline-evoked jaw muscle pain (masseter) 
inflammatory pain induced by CFA injection into masseter 
inflammatory pain induced by carrageenan injection into masseter 
Neck and back muscles imbalanced dental occlusion 
Masticatory and temporal muscles psychological stress 
Joint  
Temporomandibular disorder (inflammatory) formalin-induced temporomandibular joint inflammation 
CFA-induced temporomandibular joint inflammation 
mustard oil-induced temporomandibular joint inflammation 
Temporomandibular disorder (arthralgia) iodoacetate-induced temporomandibular joint osteoarthritis 
Neuralgia  
Trigeminal neuralgia 
Postherpetic neuralgia  
trigeminal formalin-evoked pain 
capsaicin evoked trigeminal pain 
chronic constriction injury of the infraorbital nerve 
Atypical trigeminal neuropathic pain trigeminal nerve transection 
spared nerve (infraorbital trigeminal) injury 
Facial nerve neuralgia facial nerve clamping (reversible damage) 
Idiopathic facial pain (atypical)  facial nerve transection (irreversible damage) 
Atypical odontalgia 
Phantom tooth pain 
extraction of mandibular first molar 
Laryngeal nerve of Wrisberg neuralgia – 
Glossopharyngeal nerve neuralgia – 
Upper laryngeal nerve neuralgia  – 
Burning mouth syndrome  
zinc deficiency intake 
Oncological   
Oral squamous carcinoma 4-NQO-induced squamous cell carcinoma of the tongue 
squamous cell carcinoma inoculated into the tongue 
squamous cell carcinoma inoculated into the lower gum 
squamous cell carcinoma inoculated into the whisker-pad 
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Oclussal trauma – 
Necrotising ulcerative gingivitis – 
Necrotising ulcerative periodontitis – 
Necrotising sialometaplasia – 
Acute necrotising sialoadenitis – 
Sialolitiasis – 
Acute bacterian Parotiditis – 
Acute epidemic Parotiditis – 
Candidiasis – 
Facial   
Facial inflammatory pain trigeminal formalin-evoked pain 
capsaicin evoked trigeminal pain 
carrageenan edema in the vibrissal pad 
CFA edema in the vibrissal pad 
Muscle  
Myofascial  glutamate-evoked jaw muscle pain (masseter) 
hypertonic saline-evoked jaw muscle pain (masseter) 
inflammatory pain induced by CFA injection into masseter 
inflammatory pain induced by carrageenan injection into masseter 
Neck and back muscles imbalanced dental occlusion 
Masticatory and temporal muscles psychological stress 
Joint  
Temporomandibular disorder (inflammatory) formalin-induced temporomandibular joint inflammation 
CFA-induced temporomandibular joint inflammation 
mustard oil-induced temporomandibular joint inflammation 
Temporomandibular disorder (arthralgia) iodoacetate-induced temporomandibular joint osteoarthritis 
Neuralgia  
Trigeminal neuralgia 
Postherpetic neuralgia  
trigeminal formalin-evoked pain 
capsaicin evoked trigeminal pain 
chronic constriction injury of the infraorbital nerve 
Atypical trigeminal neuropathic pain trigeminal nerve transection 
spared nerve (infraorbital trigeminal) injury 
Facial nerve neuralgia facial nerve clamping (reversible damage) 
Idiopathic facial pain (atypical)  facial nerve transection (irreversible damage) 
Atypical odontalgia 
Phantom tooth pain 
extraction of mandibular first molar 
Laryngeal nerve of Wrisberg neuralgia – 
Glossopharyngeal nerve neuralgia – 
Upper laryngeal nerve neuralgia  – 
Burning mouth syndrome  
zinc deficiency intake 
Oncological   
Oral squamous carcinoma 4-NQO-induced squamous cell carcinoma of the tongue 
squamous cell carcinoma inoculated into the tongue 
squamous cell carcinoma inoculated into the lower gum 
squamous cell carcinoma inoculated into the whisker-pad 
Table 1 continue: Summary table of the different animal models for the study of the numerous types of orofacial pain:
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